Cargando…

1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer

BACKGROUND AND AIM: Multiparametric-magnetic resonance imaging (mp-MRI) is the main imaging modality used for prostate cancer detection. The aim of this study is to evaluate the diagnostic performance of mp-MRI at 1.5-Tesla (1.5-T) for the detection of clinically significant prostate cancer. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: POPITA, CRISTIAN, POPITA, ANCA RALUCA, SITAR-TAUT, ADELA, PETRUT, BOGDAN, FETICA, BOGDAN, COMAN, IOAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305086/
https://www.ncbi.nlm.nih.gov/pubmed/28246496
http://dx.doi.org/10.15386/cjmed-690
_version_ 1782506993476435968
author POPITA, CRISTIAN
POPITA, ANCA RALUCA
SITAR-TAUT, ADELA
PETRUT, BOGDAN
FETICA, BOGDAN
COMAN, IOAN
author_facet POPITA, CRISTIAN
POPITA, ANCA RALUCA
SITAR-TAUT, ADELA
PETRUT, BOGDAN
FETICA, BOGDAN
COMAN, IOAN
author_sort POPITA, CRISTIAN
collection PubMed
description BACKGROUND AND AIM: Multiparametric-magnetic resonance imaging (mp-MRI) is the main imaging modality used for prostate cancer detection. The aim of this study is to evaluate the diagnostic performance of mp-MRI at 1.5-Tesla (1.5-T) for the detection of clinically significant prostate cancer. METHODS: In this ethical board approved prospective study, 39 patients with suspected prostate cancer were included. Patients with a history of positive prostate biopsy and patients treated for prostate cancer were excluded. All patients were examined at 1.5-T MRI, before standard transrectal ultrasonography–guided biopsy. RESULTS: The overall sensitivity, specificity, positive predictive value and negative predictive value for mp-MRI were 100%, 73.68%, 80% and 100%, respectively. CONCLUSION: Our results showed that 1.5 T mp-MRI has a high sensitivity for detection of clinically significant prostate cancer and high negative predictive value in order to rule out significant disease.
format Online
Article
Text
id pubmed-5305086
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-53050862017-02-28 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer POPITA, CRISTIAN POPITA, ANCA RALUCA SITAR-TAUT, ADELA PETRUT, BOGDAN FETICA, BOGDAN COMAN, IOAN Clujul Med Original Research BACKGROUND AND AIM: Multiparametric-magnetic resonance imaging (mp-MRI) is the main imaging modality used for prostate cancer detection. The aim of this study is to evaluate the diagnostic performance of mp-MRI at 1.5-Tesla (1.5-T) for the detection of clinically significant prostate cancer. METHODS: In this ethical board approved prospective study, 39 patients with suspected prostate cancer were included. Patients with a history of positive prostate biopsy and patients treated for prostate cancer were excluded. All patients were examined at 1.5-T MRI, before standard transrectal ultrasonography–guided biopsy. RESULTS: The overall sensitivity, specificity, positive predictive value and negative predictive value for mp-MRI were 100%, 73.68%, 80% and 100%, respectively. CONCLUSION: Our results showed that 1.5 T mp-MRI has a high sensitivity for detection of clinically significant prostate cancer and high negative predictive value in order to rule out significant disease. Iuliu Hatieganu University of Medicine and Pharmacy 2017 2017-01-15 /pmc/articles/PMC5305086/ /pubmed/28246496 http://dx.doi.org/10.15386/cjmed-690 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Original Research
POPITA, CRISTIAN
POPITA, ANCA RALUCA
SITAR-TAUT, ADELA
PETRUT, BOGDAN
FETICA, BOGDAN
COMAN, IOAN
1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title_full 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title_fullStr 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title_full_unstemmed 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title_short 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
title_sort 1.5-tesla multiparametric-magnetic resonance imaging for the detection of clinically significant prostate cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305086/
https://www.ncbi.nlm.nih.gov/pubmed/28246496
http://dx.doi.org/10.15386/cjmed-690
work_keys_str_mv AT popitacristian 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer
AT popitaancaraluca 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer
AT sitartautadela 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer
AT petrutbogdan 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer
AT feticabogdan 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer
AT comanioan 15teslamultiparametricmagneticresonanceimagingforthedetectionofclinicallysignificantprostatecancer